omeprazole has been researched along with Peritonitis in 5 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Peritonitis: INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In 84 consecutive cirrhotic patients, bacterial infection risk was prospectively assessed and related to PPI use." | 1.38 | Bacterial infections in cirrhosis: role of proton pump inhibitors and intestinal permeability. ( de Rooij, FW; Huisman, EJ; Renooij, W; Siersema, PD; van Erpecum, KJ; van Hoek, B; van Vlerken, LG, 2012) |
| "Primary lymph node gastrinomas are relatively rare in children and, to the best of our knowledge, have not previously been reported at this location." | 1.37 | Long-term follow-up of a child with primary lymph node gastrinoma and Zollinger-Ellison syndrome. ( Nazir, Z, 2011) |
| "Exploration found volvulus and a gangrenous segment of the distal ileum." | 1.32 | Massive gastrointestinal bleeding in infants with ascariasis. ( Chedphaopan, J; Mitamun, W; Patrapinyokul, S; Sangkhathat, S; Wudhisuthimethawee, P, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takata, K | 1 |
| Fukuda, H | 1 |
| Umeda, K | 1 |
| Yamauchi, R | 1 |
| Fukuda, S | 1 |
| Kunimoto, H | 1 |
| Tanaka, T | 1 |
| Yokoyama, K | 1 |
| Morihara, D | 1 |
| Takeyama, Y | 1 |
| Irie, M | 1 |
| Shakado, S | 1 |
| Sakisaka, S | 1 |
| Balza, E | 1 |
| Piccioli, P | 1 |
| Carta, S | 1 |
| Lavieri, R | 1 |
| Gattorno, M | 1 |
| Semino, C | 1 |
| Castellani, P | 1 |
| Rubartelli, A | 1 |
| Nazir, Z | 1 |
| van Vlerken, LG | 1 |
| Huisman, EJ | 1 |
| van Hoek, B | 1 |
| Renooij, W | 1 |
| de Rooij, FW | 1 |
| Siersema, PD | 1 |
| van Erpecum, KJ | 1 |
| Sangkhathat, S | 1 |
| Patrapinyokul, S | 1 |
| Wudhisuthimethawee, P | 1 |
| Chedphaopan, J | 1 |
| Mitamun, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Proton Pump Inhibitors (PPI) as a New Strategy for Therapy in Sepsis: Clinical Trial to Reduce Severity of Organ Failure and in Vitro Experiments to Search Specific Hallmarks in Monocytes From Septic Patients and to Characterize the Mechanism of Action of[NCT03452865] | Phase 3 | 300 participants (Anticipated) | Interventional | 2020-01-28 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for omeprazole and Peritonitis
| Article | Year |
|---|---|
Fitz-Hugh-Curtis syndrome in a man positive for Chlamydia trachomatis.
Topics: Abdominal Pain; Anti-Bacterial Agents; Anti-Ulcer Agents; Chlamydia Infections; Chlamydia trachomati | 2018 |
4 other studies available for omeprazole and Peritonitis
| Article | Year |
|---|---|
Proton pump inhibitors protect mice from acute systemic inflammation and induce long-term cross-tolerance.
Topics: Animals; Cryopyrin-Associated Periodic Syndromes; Esomeprazole; Gene Expression Regulation; Humans; | 2016 |
Long-term follow-up of a child with primary lymph node gastrinoma and Zollinger-Ellison syndrome.
Topics: Abdominal Pain; Anti-Ulcer Agents; Child; Combined Modality Therapy; Diarrhea; Duodenal Ulcer; Follo | 2011 |
Bacterial infections in cirrhosis: role of proton pump inhibitors and intestinal permeability.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Animals; Bacteria; Bacterial Infections; Cohor | 2012 |
Massive gastrointestinal bleeding in infants with ascariasis.
Topics: Animals; Anthelmintics; Ascariasis; Ascaris lumbricoides; Blood Transfusion; Child, Preschool; Combi | 2003 |